期刊文献+

大蒜素抗白血病作用的研究 被引量:1

Effect of allicin on bone marrow mononuclear cells of acute mycloid leukemia
暂未订购
导出
摘要 目的研究大蒜素(allicin)对急性髓系白血病(AML)患者骨髓单个核细胞(BMMNC)的作用并探讨其机制。方法采用大蒜素在体外作用于AML患者BMMNC,经MTT法、TdT缺口末端标记(TUNEL)技术、RT-PCR等方法检测大蒜素对AML患者BMMNC的影响。结果不同浓度大蒜素对AML患者BMMNC有不同程度的生长抑制、诱导凋亡和抑制iNOSmRNA表达的作用。①MTT法检测大蒜素对细胞的增殖抑制作用,发现大蒜素在3个浓度范围内对细胞均有增殖抑制作用,并呈量效关系。②TUNEL检测见阳性细胞核深染,大蒜素处理组与对照组比较,凋亡细胞明显增多。③RT-PCR检测发现大蒜素能显著抑制iNOSmRNA表达。结论大蒜素可抑制AML患者BMMNC生长、诱导期凋亡及抑制iNOSmRNA表达。 OBJECTIVE To study the effect of allicin on bone marrow mononuclear cells(BMMNC) of the patients with acute myeloid leukemia (AML). METHODS BMMNC of AML patients were treated with allicin in vitro. MTT,TUNEL and RT-PCR were used to investigate the effects. RESULTS ( 1 ) Compared with the control group, the number of BMMNC of AML patients in allicin group decreased obviously ; and has a relationship between dosage and effection. (2) Positive cells of hyperchromism were observed with TUNEL. Apototic cells increased significantly in allicin group, compared with the control group. (3)Compared with the control group ,the expression of iNOS mRNA in allicin group decreased obviously;and has a relationship between dosage and effection. CONCLUSION Allicin can inhibit the proliferation, induce the apoptosis and suppress the iNOS mRNA expression in BMMNC of AML patients in vitro.
作者 郑燕华
出处 《海峡药学》 2007年第12期31-33,共3页 Strait Pharmaceutical Journal
关键词 大蒜素 白血病 凋亡 RT-PCR Allicin Leukemia Apoptosis RT-PCR
  • 相关文献

参考文献6

二级参考文献49

  • 1徐伟,肖宣,柳雪枚.中药露蜂房水溶性蛋白NV-PP-4的分离纯化及部分理化性质鉴定[J].药学实践杂志,2000,18(5):284-285. 被引量:17
  • 2高玉民.大蒜化学性质及抗肿瘤作用[J].国外医学(中医中药分册),1993,15(1):1-4. 被引量:18
  • 3Fukushima S,Takada N,Hori T,et al.Cancer prevention by organosulfur compounds from garlic and onin[J].J Cell Biochem Suppl,1997,27:100.
  • 4Dorant E,Brand PA,Goldbohm RA,et al.Galic and its signifivancefor the prevention of cancer in humans:a critical view[J].Br J Cancer,1993,67:424.
  • 5Reifenberger J,Knobbe CB,Sterzinger AA,et al.Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas[J].Int J Cancer,2004,109 (3):377.
  • 6Kalas W,Gilpin S,Yu JL,et al.Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxy-cycline[J].Biochem Biophys Res Commun,2003,310(1):109.
  • 7[1]Neurath M F, Finotto S, Fuss I, et al. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question[J]. Trends Immunol, 2001,22(1):21-26.
  • 8[2]Suzuki A, Sugimura K, Ohtsuka K, et al. Fas/Fas ligand expression and characteristics of primed CD45RO+ T cells in the inflamed mucosa of ulcerative colitis[J]. Scand J Gastroenterol, 2000,35(12):1278-1283.
  • 9[3]Ueyama H, Kiyohara T, Sawada N, et al. High fas ligand expression on lymphocytes in lesions of ulcerative colitis[J]. Gut, 1998,43(1):48-55.
  • 10[4]Boirivant M, Marini M, Di Felice G, et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis[J]. Gastroenterology, 1999,116(3):557-565.

共引文献90

同被引文献28

  • 1张洁,滕镕.丙戊酸钠联合三氧化二砷对HL-60细胞株的体外研究[J].南通大学学报(医学版),2008,28(1):20-22. 被引量:5
  • 2王红祥,邹萍,赵湜.人重组可溶性肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导急性髓系白血病细胞凋亡的实验研究[J].中国实验血液学杂志,2004,12(6):766-769. 被引量:3
  • 3Wang L,Zhao WL,Yan JS,et al.Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-κB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner[J].Cell Death Differ,2007,14(2):306-317.
  • 4Chen S,Gao J,Halicka HD,et al.The cytostatic and cytotoxic effects of oridonin (Rubescenin),a diterpenoid from Rabdosia rubescens,on tumor cells of different lineage[J].Int J Oncol,2005,26(3):579-588.
  • 5Zhon GB,Kang H,Wang L,et al.Oridonin,a diterpenoid extracted from medicinal herbs,targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo[J].Blood,2007,109(8):3441-3450.
  • 6Lirditti FD,Rabinkov A,Miron T.Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in si-tu using a rituximab-alliinase conjugate[J].Mol Cancer Ther,2005,4(2):325-331.
  • 7Tazzari PL,Tabellini G,Ricci F,et al.Synergistic Proapoptotic Activity of Recombinant TRAIL Plus the Akt Inhibitor Perifosine in Acute Myelogenous Leukemia Cells[J].Cancer Res,2008,68(22):9394-9403.
  • 8Kaiser M,Zavrski I,Sterz J,et al.The effects of the histone deacetylase inhibitor valproic acid on cell cycle,growth suppression and apoptosis in multiple myeloma[J].Haematologica,2006,91(2):248-251.
  • 9Lancet JE,Baer MR,Duran GE,et al.A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunornhicin and cytarabine in acute myeloid leukemia[J].Leuk Res,2009,33(8):1055-1061.
  • 10Lancet JE,Gojo I,Gotlib J,et al.A phase 2 study of tbe farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia[J].Blood,2007,109(4):1387-1394.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部